scholarly journals Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium

2010 ◽  
Vol 51 (8) ◽  
pp. 1523-1529 ◽  
Author(s):  
Ajay K. Gopal ◽  
Oliver W. Press ◽  
Andrei R. Shustov ◽  
Stephen H. Petersdorf ◽  
Ted A. Gooley ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Puget Sound ◽  
Efficacy And Safety ◽  
Refractory Lymphoma

scholarly journals Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

2018 ◽  
Vol 105 ◽  
pp. 114-126 ◽  
Author(s):  
Kenjiro Namikawa ◽  
Yoshio Kiyohara ◽  
Tatsuya Takenouchi ◽  
Hisashi Uhara ◽  
Hiroshi Uchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Multicentre Phase

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

2010 ◽  
Vol 123 (3) ◽  
pp. 837-842 ◽  
Author(s):  
Phuong K. Morrow ◽  
Stephen Divers ◽  
Louise Provencher ◽  
Shiuh-Wen Luoh ◽  
Teresa M. Petrella ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of Multiple Doses of Imab362 in Patients with Advanced Gastro-Esophageal Cancer: Results of a Phase Ii Study

2014 ◽  
Vol 25 ◽  
pp. iv218 ◽  
Author(s):  
T. Trarbach ◽  
M. Schuler ◽  
Z. Zvirbule ◽  
F. Lordick ◽  
A. Krilova ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Efficacy And Safety ◽  
Multiple Doses

scholarly journals A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma

2011 ◽  
Vol 13 (4) ◽  
pp. 437-446 ◽  
Author(s):  
P. Y. Wen ◽  
D. Schiff ◽  
T. F. Cloughesy ◽  
J. J. Raizer ◽  
J. Laterra ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Glioblastoma ◽  
Efficacy And Safety

scholarly journals Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma

2018 ◽  
Vol 23 (8) ◽  
pp. 889 ◽  
Author(s):  
Mary Lou Affronti ◽  
Jennifer Gamboa Jackman ◽  
Frances McSherry ◽  
James E. Herndon ◽  
Elwood C. Massey ◽  
...  
Keyword(s):  
Malignant Glioma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Efficacy And Safety ◽  
Recurrent Malignant Glioma
Sign in / Sign up

Export Citation Format

Share Document